穴位贴敷和穴位注射治疗慢性支气管炎疗效对比研究

Comparative Study on Acupoint Application Versus Acupoint Injection for Chronic Bronchitis

目的观察穴位注射和穴位贴敷治疗慢性支气管炎缓解期肺气亏虚证患者的临床疗效。方法将163例慢性支气管炎患者随机分为A组78例和B组85例。A组采用穴位贴敷治疗,B组采用穴位注射治疗。观察两组治疗前后中医证候评分、治疗后6个月内感冒发作次数、生存质量评分及肺功能检测评分。结果两组治疗后中医证候评分与同组治疗前比较,差异均具有统计学意义(P<0.05)。两组治疗后6个月内感冒次数比较,差异无统计学意义(P>0.05)。A组治疗后各项生存质量评分(FS1、FS2、FS3、FS4及TMS)与同组治疗前比较,差异均具有统计学意义(P<0.05)。B组治疗后FS1评分与同组治疗前比较,差异具有统计学意义(P<0.05)。两组治疗后肺功能检测各项指标(FEV1.0%、V50、V25、FVC、FEV1.0)与同组治疗前比较,差异均具有统计学意义(P<0.05)。结论穴位贴敷和穴位注射均能显著改善慢性支气管炎患者的临床证候、生存质量及肺功能。

Objective To observe the clinical efficacies of acupoint injection versus acupoint application in treating patients with chronic bronchitis due to lung-qi deficiency in remission stage. Method Totally 163 patients with chronic bronchitis were randomized into group A of 78 cases and group B of 85 cases. Group A was intervened by acupoint application, while the control group was by acupoint injection. The syndrome score of traditional Chinese medicine（TCM） was evaluated before and after treatment, the attack frequency of cold, quality of life, and pulmonary function were observed in the 6-month follow-up. Result The TCM syndrome scores were significantly changed after treatment in both groups（P〈0.05）. There was no significant inter-group difference in comparing the attack frequency of cold in the 6-month follow-up（P〈0.05）. The scores of quality of life（FS1, FS2, FS3, FS4 and TMS） in group A were significantly changed after treatment（P〈0.05）. The FS1 score in group B was remarkably changed after treatment（P〈0.05）. The parameters of pulmonary function（FEV1.0%, V50, V25, FVC, FEV1.0） were significantly changed after treatment in both groups（P〈0.05）. Conclusion Acupoint application and acupoint injection both can significantly improve the symptoms, quality of life, and pulmonary function in chronic bronchitis.